Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to
reach more than five million people in developing countries. Essential to this achievement …
reach more than five million people in developing countries. Essential to this achievement …
Promoting versatile vaccine development for emerging pandemics
The ongoing COVID-19 pandemic has demonstrated the importance of rapid and versatile
development of emergency medical countermeasures such as vaccines. We discuss the role …
development of emergency medical countermeasures such as vaccines. We discuss the role …
[HTML][HTML] Global health governance at a crossroads
NY Ng, JP Ruger - Global health governance: the scholarly journal …, 2011 - ncbi.nlm.nih.gov
This review takes stock of the global health governance (GHG) literature. We address the
transition from international health governance (IHG) to global health governance, identify …
transition from international health governance (IHG) to global health governance, identify …
Rethinking the'global'in global health: a dialectic approach
K Bozorgmehr - Globalization and health, 2010 - Springer
Background Current definitions of'global health'lack specificity about the term'global'. This
debate presents and discusses existing definitions of'global health'and a common problem …
debate presents and discusses existing definitions of'global health'and a common problem …
Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?
As part of a cluster of articles leading up to the 2012 World Health Report and critically
reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue …
reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue …
Orphan drugs policies: a suitable case for treatment
M Drummond, A Towse - The European Journal of Health Economics, 2014 - Springer
Context Current orphan drug policies are unsatisfactory when viewed from almost all
perspectives. Patients find that, although therapies are available for many rare conditions …
perspectives. Patients find that, although therapies are available for many rare conditions …
The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials
Background To assess the blood pressure and lipid-lowering efficacy and tolerability of
'polypills' used in cardiovascular disease prevention trials. Methodology/Principal Findings …
'polypills' used in cardiovascular disease prevention trials. Methodology/Principal Findings …
[PDF][PDF] Drug-resistant infection: Causes, consequences, and responses
E Jamrozik, MJ Selgelid - Ethics and drug resistance: Collective …, 2020 - library.oapen.org
This chapter provides an overview of the causes and consequences of, and possible policy
responses to, the problem of drug resistance. Throughout, we highlight the ways that ethical …
responses to, the problem of drug resistance. Throughout, we highlight the ways that ethical …
[图书][B] Cosmopolitan responsibility
JC Heilinger - 2019 - library.oapen.org
The world we live in is unjust. Preventable deprivation and suffering shape the lives of many
people, while others enjoy advantages and privileges aplenty. Cosmopolitan responsibility …
people, while others enjoy advantages and privileges aplenty. Cosmopolitan responsibility …
[PDF][PDF] National, regional, and sectoral systems of innovation–an overview
B Schrempf, D Kaplan… - Report for FP7 Project « …, 2013 - progressproject.eu
An innovation system: can be defined as a group of private firms, public research institutes,
and several of the facilitators of innovation, who in interaction promote the creation of one or …
and several of the facilitators of innovation, who in interaction promote the creation of one or …